World Health Organization Approving Vaccine Covid 19 of Chinese Pharmaceutical Sinopharm for use in emergencies.

"WHO brought Vaccine Covid-19 of Sinopharm in Beijing to the list of emergency use. This is the 6th vaccine that is certified by WHO on safety, efficiency and essence", WHO Director Tedros Adhanom Ghebreyesu said

"Strategic advisory group includes vaccinated professionals (Sage) that reviewed data and recommends using this two-tender vaccine for people aged 18 and over," Tedros said.

Vaccine Covid-19 The World Health Organization's Emergency (WHO) includes products of Pfizer-Biontech, Moderna, Johnson & Johnson, Astrazeneca and Sinopharm.

Vaccine Covid-19 of Chinese Pharmaceutical Sinopharm at a vaccination point in the North Macedonia Republic on May 6.

WHO's emergency use list paves its ways for countries around the world to quickly approve and import vaccines for injections for people, especially those who do not have their own international management agencies.

The list opened the door for Vaccine Covid-19 to join the global vaccine access program (Covax), to provide equal access to this product worldwide, especially in countries subject

Vaccine Covid-19 of Sinopharm is used in 42 countries and territories around the world, behind Astrazeneca (166), Pfizer-BionTech (94) and Moderna (46).

Some other Covid-19 vaccines are being reviewed on WHO's emergency use list, including products produced by Sinopharm factory in Wuhan.